Silverback Therapeutics, Inc.
ANTIBODY CONJUGATES OF IMMUNE-MODULATORY COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

Antibody conjugates of immune-modulatory compounds and pharmaceutical compositions for use in the treatment of disease, such as fibrotic diseases, autoimmune, or autoinflammatory diseases, are disclosed herein. The disclosed conjugates are useful, among other things, in treating fibrotic diseases, autoimmune diseases, or autoinflammatory diseases, such as by modulating TGF.beta.R1, TGF.beta.R2, TNKS, TNIK, or mTOR.

Status:
Application
Type:

Utility

Filling date:

7 Jun 2018

Issue date:

25 Jun 2020